Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RC
Avita Medical, Inc. Common Stock
RCEL
Mkt Cap
$403.9M
Volume
300.38K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RC
RCEL
RC
Avita Medical, Inc. Common Stock
RCEL
News
·
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
Mkt Cap
$414.7M
Volume
300.38K
Next Earnings
November 5th
Chart
Financials
Earnings
News
About
Insider
Filings
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
AVITA Medical announced its participation at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11-13, 2026. CEO Cary Vance will speak on August 12 at 8:00 a.m. ET, with a live webcast available on the company's investor relations website.
GlobeNewswire Inc. · Aug 7, 2026
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally
The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatments. The U.S. market alone is expected to reach USD 17.69 billion by 2033.
GlobeNewswire Inc. · Feb 18, 2026
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
AVITA Medical presented 19 scientific abstracts at the 2026 Boswick Burn & Wound Symposium, including the first surgeon-reported integrated use of its three technologies (RECELL, PermeaDerm, and Cohealyx) in patient cases. New clinical and histological data demonstrated that RECELL use was associated with smaller donor sites, faster healing times, improved pain and appearance outcomes, and more favorable health economics. Real-world studies showed RECELL reduced hospital stays by up to 36% in deep partial-thickness burns and nearly 16 days shorter stays in elderly burn patients.
GlobeNewswire Inc. · Jan 25, 2026
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
Law firm Bragar Eagel & Squire is investigating potential securities violations at three companies: Soleno Therapeutics following a report questioning its product's safety and pricing, AVITA Medical due to significant claim payment backlogs affecting product utilization, and Coty following unexpected losses and disappointing guidance attributed to market challenges.
GlobeNewswire Inc. · Jan 8, 2026
AVITA Medical Announces CEO Transition
AVITA Medical announced Cary Vance as Interim CEO, replacing Jim Corbett. The company expects Q3 2025 revenue of approximately $17 million and is seeking a permanent CEO through an executive search.
GlobeNewswire Inc. · Oct 16, 2025
AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
Law firm investigating potential claims against AVITA Medical after company reported significant backlog of unpaid provider claims for Recell procedures, causing stock price to decline by 21%.
GlobeNewswire Inc. · Oct 16, 2025
MAREX REMINDER: Bragar Eagel & Squire, P.C. Reminds Marex Group Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Marex Stockholders
Law firm investigating potential securities law violations by Marex Group after a research report alleging accounting irregularities caused stock price decline.
GlobeNewswire Inc. · Oct 9, 2025
AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire is investigating potential claims against AVITA Medical after the company reported a six-month backlog in unpaid provider claims for Recell procedures, which caused a 21% stock price decline.
GlobeNewswire Inc. · Oct 9, 2025
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
AVITA Medical reported a six-month backlog in unpaid provider claims for Recell procedures, causing uncertainty among providers and leading to reduced product utilization, which resulted in a 21% stock price drop.
GlobeNewswire Inc. · Sep 30, 2025
AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
AVITA Medical experienced significant stock decline after revealing a six-month backlog in unpaid provider claims for Recell procedures, caused by Medicare & Medicaid Services' pricing and claims adjudication issues.
GlobeNewswire Inc. · Sep 15, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
RC
RCEL
Avita Medical, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
RCEL
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any RCEL yet.
Related Tickers
Earnings